Medivation Announces Participation at Upcoming Investor Conference

Medivation Announces Participation at Upcoming Investor Conference  SAN FRANCISCO, CA -- (Marketwired) -- 01/31/14 --  Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:      --  David Hung, M.D., president and chief executive officer, will present     at the Leerink Global Healthcare Conference on Wednesday, February 12     at 11:30am ET at the Waldorf Astoria Hotel, New York, NY.     Individuals may access the live audio webcast by visiting: A replay of the webcast will be available on the Company's website for 30 days following the live event.  About Medivation  Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at  Contacts: Patrick Machado  Chief Business & Financial Officer  (415) 829-4101   Anne Bowdidge Sr. Director, Investor Relations (650) 218-6900